We are committed to serving the best interests of our shareholders. The investor pages that follow are your resource for financial information about Catalyst Biosciences, Inc.
NASDAQ: CBIO$27.040.00 (0.00%)May 21, 20184:00 p.m. ET
Delayed at least 15 minutes
Data provided by Nasdaq. Minimum 15 minutes delayed.
Press ReleasesMay 10, 2018Catalyst Biosciences Announces Oral Presentation at the World Federation of Hemophilia 2018 World CongressMay 09, 2018Catalyst Biosciences to Host Key Opinion Leader Meeting on Novel Treatments for Hemophilia B and Hemophilia with InhibitorsMay 03, 2018Catalyst Biosciences Reports First Quarter Operating & Financial Results and Provides Corporate UpdateView all press releases »
Reverse Stock Split
|For the 1 for 15 Reverse Stock Split Tax Form, click here|
Targacept Special Dividend
|For the FAQ and additional information, click here.|
Catalyst Biosciences, Inc.
|Josephine Belluardo, Ph.D.|
LifeSci Public Relations